John P. McLaughlin
2016
In 2016, John P. McLaughlin earned a total compensation of $4.1M as President and Chief Executive Officer at PDL BioPharma, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,038,090 |
|---|---|
| Salary | $800,065 |
| Stock Awards | $1,300,000 |
| Other | $10,000 |
| Total | $4,148,155 |
McLaughlin received $2M in non-equity incentive plan, accounting for 49% of the total pay in 2016.
McLaughlin also received $800.1K in salary, $1.3M in stock awards and $10K in other compensation.
Rankings
In 2016, John P. McLaughlin's compensation ranked 2,109th out of 14,075 executives tracked by ExecPay. In other words, McLaughlin earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,109 out of 14,075 | 85th |
Division Manufacturing | 725 out of 5,489 | 87th |
Major group Chemicals And Allied Products | 210 out of 1,895 | 89th |
Industry group Drugs | 151 out of 1,538 | 90th |
Industry Biological Products, Except Diagnostic Substances | 28 out of 279 | 90th |
Source: SEC filing on April 28, 2017.
McLaughlin's colleagues
We found four more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2016.